Brigida A. Maiorano
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.
Journal: Expert opinion on drug safety
Published: August 13, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Journal: Nature reviews. Urology
Published: July 22, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.
Journal: Expert review of anticancer therapy
Published: June 30, 2026
BRCA Testing in Prostate Cancer: A Histopathologist's Perspective.
Journal: Diagnostics (Basel, Switzerland)
Published: June 14, 2026
Correction: Parente et al. Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience. Diagnostics 2022, 12, 685.
Journal: Diagnostics (Basel, Switzerland)
Published: June 11, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2026
Occult invasive and preneoplastic lesions at risk-reducing salpingo-oophorectomy in BRCA1/2 carriers: A multicenter retrospective cohort study.
Journal: Gynecologic oncology
Published: May 13, 2026
Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence.
Journal: Clinical genitourinary cancer
Published: May 11, 2026
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter.
Journal: Clinical genitourinary cancer
Published: May 07, 2026
Tumor Mutational Burden Predicts the Outcome of Patients With Muscle-invasive bladder Cancer Undergoing Immune-checkpoint Inhibitor-Based Neoadjuvant Therapy.
Journal: Clinical genitourinary cancer
Published: May 03, 2026
Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection.
Journal: Frontiers in immunology
Published: April 18, 2026
Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.
Journal: ESMO open
Published: April 13, 2026
Last Updated: 09/26/2026